ENT Devices Market Size, Share & Trends Analysis Report By Product (Hearing Aids, Hearing Implants, Diagnostic ENT Devices, Surgical ENT Devices, Nasal Splints), By Region (North America, Europe, Asia Pacific), And Segment Forecasts, 2025 - 2030

ENT Devices Market Summary

The prevalence of hearing loss is increasing; it is considered one of the most common conditions affecting patients globally. According to WHO factsheet of February 2024, around 5% of the global population requires rehabilitation to address their hearing loss.

Moreover, around 2.5 billion individuals are projected to have some hearing loss by 2050, and around 700 million are expected to require hearing rehabilitation by 2050. Primary factors expected to contribute to the rise in age-related hearing loss are the increasing life expectancy and the growing noise pollution. In low-income countries, common causes of hearing impairment include infections such as measles, middle ear infections, and meningitis.

Chronic inflammation, exposure to loud noises, vascular issues, natural aging processes affecting the ear, and genetic predispositions can further contribute to the increasing prevalence of hearing impairment or loss. According to the European Hearing Instrument Manufacturers Association (EHIMA), hearing aid unit sales by its members increased by around 4.7% to reach 20.25 million units in 2022. Thus, the rise in hearing aid sales and the high prevalence of hearing loss are expected to drive the market.

Global hearing aids unit sales, 2017-2022

Source: European Hearing Instrument Manufacturers Association (EHIMA)

The demand for ENT devices is high among the elderly, driven by the increasing prevalence of hearing loss, the growing geriatric population, and the rising adoption of minimally invasive ENT procedures. In addition, geriatric patients often require specialized ENT devices for hearing aids, implants, and other related treatments, contributing to this demographic group’s high demand for ENT devices. Hearing impairment is a partial or total inability to hear. It is one of the most common conditions affecting the geriatric population. According to the National Institute on Deafness and Other Communication Disorders (NIDCD), about one out of every three people aged 65 to 74 years are affected by hearing loss, and 50% of people older than 75 years have difficulty hearing.

Furthermore, increasing penetration of minimally invasive ENT procedures is fostering market growth. Minimally invasive surgeries are gradually replacing traditional surgical methods in advanced countries, such as the U.S., UK, and Japan. Minimally invasive ENT procedures offer benefits such as reduced tissue damage, shorter operation times, and quicker patient recovery, resulting in improved patient outcomes. Traditional surgeries typically necessitate incisions to access internal body parts, requiring precision and expertise. On the other hand, minimally invasive ENT procedures offer advantages such as lower blood loss, reduced anesthesia requirements, lower infection risks, smaller incisions, shorter hospital stays, and faster recovery, often leading to better results.

Market Concentration & Characteristics

The chart below illustrates the relationship between industry concentration, industry characteristics, and industry participants. The x-axis represents the level of industry concentration, ranging from low to high. The y-axis represents various industry characteristics, including industry competition, degree of innovation, impact of regulations, level of merger & acquisition activities, and geographic expansion.

The degree of innovation is notably high, driven by continuous technological advancements, growing patient demand for minimally invasive procedures, and the need for improved diagnostic accuracy and therapeutic outcomes. Companies are investing heavily in research and development to introduce products that are smaller, more precise, and integrated with digital technologies such as AI, robotics, and image-guided systems. Innovations such as 3D-printed implants, balloon sinuplasty devices, and advanced hearing aids with wireless connectivity show the shift toward personalized and efficient care. In February 2024, GN Store Nord A/S expanded its existing portfolio of ReSound Nexia hearing aids with a new range of styles and connectivity.

Several key market players are devising business growth strategies in the form of mergers and acquisitions. Through M&A activity, these companies can expand their business. For instance, in January 2024, Karl Storz acquired Innersight Labs Ltd., which is based in London. It is a manufacturer of innovative software.

Regulations play a critical role in shaping the ENT devices market by ensuring the safety, efficacy, and quality of products. Regulatory frameworks, such as the FDA in the U.S. and the MDR (Medical Device Regulation) in Europe, govern the approval, classification, and monitoring of ENT devices. These regulations establish strict guidelines for pre-market approvals, post-market surveillance, and adverse event reporting, ensuring that devices meet safety standards before they reach patients.

Several market players are expanding their business by entering new geographical regions to strengthen their market position and expand their product portfolio. In April 2024, Karl Storz expanded its business in Belgium, Luxembourg, and the Netherlands, with the acquisition of related business of distributor Stöpler.

Product Insights

The hearing aids segment dominated the market in 2024 and accounted for the largest revenue share of 31.06% and is also anticipated to register the fastest growth rate over the forecast period. Factors expected to contribute to market growth include increasing investments, new product launches, acquisitions, & technological advancements aimed at improving hearing and accurately diagnosing ear disorders. For instance, in March 2023, EssilorLuxottica acquired Nuance Hearing, an Israel-based start-up. This acquisition was expected to help EssilorLuxottica expand its presence in the hearing aids business by developing lenses fitted with acoustic technology, aiming to gain access to new technologies and establish its position in a rapidly growing market.

The surgical ENT devices segment is anticipated to register a considerable growth rate over the forecast period. The increasing prevalence of ENT disorders, technological advancements in surgical devices, and rising demand for minimally invasive procedures are expected to drive market growth during the forecast period. In addition, efforts to promote the adoption of cochlear implants are likely to positively impact market growth. According to the World Health Organization (WHO), approximately 5% of the global population suffers from hearing loss, affecting nearly 432 million adults and 34 million children. By 2050, it is estimated that 2.5 billion people will suffer from hearing loss, with 700 million requiring hearing aids or surgery, thereby increasing the demand for cochlear implant devices.

Regional Insights

North America dominated the ENT devices industry in 2024 and accounted for the largest revenue share of 34.99%. Key factors contributing to growth of this region are growing geriatric population and increasing prevalence of hearing loss. Furthermore, approval and launch of advanced, next generation hearing devices in the U.S. & Canada and high adoption of hearing aids are likely to boost the market growth.

U.S. ENT Devices Market Trends

The ENT devices market in the U.S. held the largest share of 90.35% in 2024 due to technological advancements and recent approvals received for several hearing devices. Manufacturers are investing in R&D to obtain approvals for new products for commercialization. For instance, in December 2020, Advanced Bionics, in collaboration with Phonak, received FDA approval for Marvel hearing technology. This includes Sky CI Marvel, New Naída, and New Advanced Bionics Remote app for easy adjustments via smartphone.

Canada ENT devices market is anticipated to register the fastest growth during the forecast period. Canada's medical device market is ranked 8th in the world, and most establishments in the medical devices industry are located in British Columbia, Quebec, Ontario, and Alberta. The Canadian ENT devices market is expected to witness growth during the forecast period, which can be attributed to growing preference for minimally invasive surgical procedures, technological advancements, and increasing geriatric population suffering from ENT-related diseases.

Europe ENT Devices Market Trends

Europe ENT devices market is anticipated to register considerable growth during the forecast period. The UK, Germany, Italy, France, and Spain are the main markets in this region. Increasing geriatric population in developed countries, such as the UK, Germany, Italy, and France, are some of the factors anticipated to drive growth over the forecast period.

Germany ENT devices market is anticipated to register a significant growth rate during the forecast period. Germany is one of the countries with the fastest aging population. Factors such as increasing adoption of minimally invasive surgeries, introduction of advanced products, and other business activities, such as mergers & acquisitions, will contribute to growth of ENT devices market in Germany. For instance, in February 2023, a Germany-based company, KARL STORZ, acquired 100% of AventaMed DAC, an Irish medical technologies company, to strengthen its ENT Portfolio. AventaMed specializes in developing single-use medical devices and has created the Solo+ TTD, which is a new method of treatment addressing the current issues with ENT surgical tympanostomy procedures.

The ENT devices market in UK is anticipated to register a considerable growth rate during the forecast period. ENT UK is actively involved in developing new initiatives such as a virtual reality training simulation based on pediatric emergency national guidelines. These initiatives aim to enhance training and improve patient care in the field of ENT surgery. Thus, such factors are expected to drive the demand for technically advanced ENT devices in the country.

Asia Pacific ENT Devices Market Trends

Asia Pacific is anticipated to be the significantly growing region in the market. Technological innovations, such as real-time monitoring, wireless technology, increase in healthcare spending in the Asia Pacific region, and support from regulatory bodies are anticipated to promote growth of the ENT devices market. In addition, increasing geriatric population, coupled with growing prevalence of conditions affecting the ears, nose, and throat, are anticipated to drive the growth of ENT devices market

Japan ENT devices market held the largest share in 2024. This can be attributed to technological advancements, rising inclination for minimally invasive surgeries, increasing penetration of endoscopes for treatment & diagnosis, investment by global players, ongoing R&D, and presence of key manufacturers. According to GSK’s regulatory submission, chronic sinusitis in Japan is estimated to affect around 2 million people.

The ENT devices market in India is anticipated to register a significant growth during the forecast period. The Central Drugs Standard Control Organisation (CDSCO) in India recently issued a list of 67 ENT medical devices requiring registration and approval, including ear canal lights, ear wicks, ENT chairs, & audiometers. This is part of India's efforts to regulate the medical device industry better.

Latin America ENT Devices Market Trends

Latin America ENT devices market is anticipated to register significant growth during the forecast period. Latin America ENT devices market is primarily driven by Mexico, Brazil, Argentina, and Colombia. Growing investments by market players in the region, proximity to North America, and free-trade agreements with major countries such as the U.S., Canada, Japan, & several European countries are among the factors anticipated to boost the Latin America market during the forecast period.

Brazil ENT devices market accounted for a major share of Latin America in 2024. A large population suffering from mild-to-moderate hearing loss, coupled with rapid development of technologically advanced devices, is expected to increase the market penetration of hearing aids in the coming years.

MEA ENT Devices Market Trends

MEA ENT devices market is anticipated to register considerable growth during the forecast perioddue to the increase in the prevalence of hearing loss and the rapidly aging population, as well as the growing demand for technologically advanced devices. According to The World Bank, around 26.9 million people were aged 65 and above in 2022.

The ENT devices market in UAE is experiencing fastest growth during the forecast period. This growth is primarily driven by the increasing prevalence of ENT disorders such as sinusitis, hearing loss, and tonsillitis in the country. The UAE's high prevalence of hearing loss, sinus, and allergy-related disorders contributes to the demand for ENT equipment such as sinus irrigation devices and nasal sprays.

Key ENT Devices Company Insights

Key participants in the ENT devices market are focusing on devising innovative business growth strategies in the form of product portfolio expansions, partnerships & collaborations, mergers & acquisitions, and business footprint expansions.

Recent Developments

• In April 2024, PENTAX Medical launched Digital Capture Module 9380, designed for medical recording in ENT and speech-language settings.

• In February 2024, Sonova opened a new operations facility in Mexico to expand its cochlear implants and hearing instruments businesses.

• In February 2024, Sonova launched the Stride V-UP Ultra Power BTE hearing aid to expand its Vivante portfolio.

• In February 2024, HANSATON, a brand of Sonova, launched a beat FS RT675 UP power hearing aids as an extension to its existing portfolio.

ENT Devices Market Report Scope

Global ENT Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country level and provides an analysis on industry trends in each of the sub segments from 2018 to 2030. For the purpose of this study, Grand View Research, Inc. has segmented the global ENT devices market report on the basis of product and region:

• Product Outlook (Revenue USD Million, 2018 - 2030)

  • Diagnostic ENT Devices

    • Rigid Endoscopes

      • Sinuscopes

      • Otoscopes

      • Laryngoscopes

    • Flexible Endoscopes

      • Bronchoscopes

      • Laryngoscopes

      • Nasopharyngoscopes

    • Robot Assisted Endoscope

    • Hearing Screening Device

  • Surgical ENT Devices

    • Radiofrequency handpieces

    • Otological Drill Burrs

    • ENT Hand Instruments

    • Sinus Dilation Devices

    • Nasal Packing Devices

    • Others

  • Hearing Aids

  • Hearing Implants

  • Nasal Splints

• Regional Outlook Revenue USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • Germany

    • UK

    • Spain

    • Italy

    • France

    • Denmark

    • Norway

    • Sweden

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • Thailand

    • South Korea

  • Latin America

    • Brazil

    • Argentina

  • MEA

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait